DVA DaVita
$180.40 +0.94%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.94%
YTD
+37.70%
P/E
13.52
P/B
101.25
ROE
181.2%
Div yield
—
Beta
0
Market cap
$11.5B
RSI (14)
48
Next earnings
Oct 23, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$179.88
Close
$180.40
VWAP (n/a)
—
Day high
$181.82
Day low
$178.88
Volume
374K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
DaVita (DVA) Stock May Be Undervalued On Its Earnings Power
Yahoo Finance · Sep 29
This Warren Buffett Stock Is Up 58%. History Says This Is What Happens Next.
Yahoo Finance · Sep 29
1 Profitable Stock with Competitive Advantages and 2 That Underwhelm
Yahoo Finance · Sep 24
Is DaVita Stock Underperforming the S&P 500?
Yahoo Finance · Sep 23
3 Surging Stocks That Don’t Need the AI Boom to Keep Winning
Yahoo Finance · Sep 21
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
Yahoo Finance · Sep 9
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K Jun 8, 2026 View → 10-Q May 5, 2026 View → 8-K May 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell DVA. Try it in the Lab to size a position and see the risk.